Wall Street Associates’s MacroGenics MGNX Stock Holding History

Wall Street Associates’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-28,091	Closed	-$870K	–	250
2015 Q4	$870K	Sell	28,091 -1,450	-5%	-$44K	0.24%	146
2015 Q3	$633K	Buy	29,541 +21,959	+290%	+$689K	0.12%	201
2015 Q2	$288K	Hold	7,582	–	–	0.03%	317
2015 Q1	$238K	Hold	7,582	–	–	0.02%	315
2014 Q4	$266K	Sell	7,582 -3,698	-33%	-$92.2K	0.03%	304
2014 Q3	$236K	Hold	11,280	–	–	0.02%	318
2014 Q2	$245K	Sell	11,280 -500	-4%	-$10.5K	0.02%	310
2014 Q1	$328K	Sell	11,780 -6,709	-36%	-$237K	0.03%	296
2013 Q4	$507K	Buy	+18,489	New	+$484K	0.04%	268

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wall Street Associates's MGNX Position: Q1 2016 in Review

Wall Street Associates sold out of MacroGenics (MGNX) in Q1 2016, closing a stake of 28,091 shares — an estimated $870K sold.

Wall Street Associates first reported a position in MGNX in Q4 2013 and held it in 9 quarters. The position peaked at $870K in Q4 2015. 126 funds tracked by Wall St. Rank hold MGNX as of Q1 2016.

Wall Street Associates reported no remaining MacroGenics position as of Q1 2016 after selling out during the quarter.
Wall Street Associates sold 28,091 MacroGenics shares in Q1 2016, an estimated $870K.
Wall Street Associates first reported a position in MacroGenics in Q4 2013 and held it in 9 quarters.
Wall Street Associates's MacroGenics position peaked at $870K in Q4 2015.
126 funds tracked by Wall St. Rank held MacroGenics as of Q1 2016.

Based on Wall Street Associates's 13F filing for Q1 2016, filed 13 May 2016.